PrecisionPanc
@precisionpanc
Followers
2K
Following
6K
Media
424
Statuses
5K
A UK platform comprised of an enthusiastic team of clinicians and researchers to accelerate therapeutic development for pancreatic cancer
United Kingdom
Joined January 2015
Precision-Panc are delighted that PRIMUS 006 has opened to recruitment. Read all about t below. Currently Glasgow open to recruitment but many more UK sites to come
π .@UofGlasgow, alongside @NHSGGC, has opened the PRIMUS-006 pancreatic cancer study, part of the @precisionpanc platform. The Phase II study will evaluate a new drug combination as first-line treatment in patients with metastatic pancreatic cancer. β‘οΈ https://t.co/Nq6IEE6A34
0
3
14
Hold the date! Announcing the 1st @CR_UK #PancreaticCancer conference. 7-9 July 2026 in London, π¬π§ More details to followβ¦..
2
13
73
Weβre inviting international, multidisciplinary teams to propose creative approaches to address some of the toughest questions in cancer research. ποΈ EOIs close 18 June π Apply now: https://t.co/lYqOkRWH92
#CancerGrandChallenges
0
6
8
Today the public has rallied behind us as we have powerfully demonstrated the devastating impact of #PancreaticCancer in the UK. It is unacceptable that 797 people die of this cruel disease every month. We need to do more. Early detection is vital to improve survival rates.
4
28
60
.@UofGlasgow researchers are among the team of European clinicians and scientists who form CRC-STARS, a world-leading research team tasked with making personalised medicine a reality for people with bowel cancer. @CRUKresearch @BowelbabeF @UofGMVLS β‘οΈ https://t.co/g3nbRqkDw1
1
11
21
β³ Closing soon! Complete by April 17th β
Queen's University Belfast & NIPANC are surveying the needs of those supporting a loved one with #pancreaticcancer. Your input can help shape future support! π Participate: https://t.co/0DQH6Zqkbm
0
19
21
Thank you to our amazing supporters who spoke to over 70 MPs in Parliament today about the need to #EndPERTShortages. Pancreatic Enzyme Replacement Therapy (PERT) is essential for people with #PancreaticCancer: we wonβt stop campaigning until everyone who needs PERT can get it.
0
7
33
π Fighting for early diagnosis! Our founder and spokesperson Ali Stunt spoke at the European Parliament's PANCAID event, advocating for research to develop early detection tools for pancreatic cancer. Let's drive change together. π Read more: https://t.co/w5RA0ix7TP
0
1
7
π We are incredibly proud to announce that the @UofGCancerSci has been awarded the prestigious Athena Swan Gold Award from Advance HE! π Explore https://t.co/16ZRtdoK3E
#MVLS
0
8
35
Register for our seminar on #imaging innovation on the 20th of March! Join us as we explore cutting-edge imaging technologies, address key challenges in clinical adoption, and connect with peers to spark new collaborations. π’ Registration is open! π: https://t.co/596HxlQpTn
0
4
4
Today is #WorldCancerDay. @UofGlasgow & Glasgow city are pioneers in cancer research & treatment. Hear from Head of School, Prof Chris Halsey, about the innovations from last 50 years of @UofGCancerSci π¬ Support cancer sciences at UofG: https://t.co/guJXprSs8Q
@UofGMVLS
1
16
35
We are delighted to see @GwynneMP committing to improving outcomes for those with less survivable cancers. Greater research is key to developing better treatments.
independent.co.uk
Andrew Gwynne, who lost his parents to cancer, told the Commons tackling rarer types will be a βcrucial partβ of the emerging national cancer plan.
8
4
9
Our team brought #PrecisionMedicine to life at St Paul's High School this week!𧬠We spoke with young people and their families about what precision medicine is, the exciting career opportunities it offers, and how to explore pathways into their preferred fields. #STEMCareers
0
1
3
New @JAMANetworkOpen study by @GarridoLagunaMD in collaboration with @FoundationATCG @flatironhealth on the impact of KRAS allelic status on outcomes in #PancreaticCancer. In ~2500 patients, those with wild type KRAS have the most favorable outcomes followed by G12R and then
4
15
51
It's the first day of Less Survivable Cancers Awareness Week and as one of the less survivable cancers we want to amplify the urgent need for more research into early detection methods and better treatment for those affected by pancreatic cancer. https://t.co/gZFyJHtDHd
1
9
17
All previous webinar sessions are now available to watch at your convenience! Our webinar series showcases insights from leaders across diverse fields, highlighting the critical role of a thriving #HealthcareInnovation ecosystem. Access the playlist π https://t.co/G33a7HnjRB
0
2
3
Over the last 10 years I have been involved in many research projects for pancreatic cancer especially @precisionpanc it was great to spend time with researchers in Glasgow #sethslegacy #PostItPurple4Seth
0
3
10
π Exciting days at the #PanCKI Congress hosted by Karolinska Institutet! π¬ A multidisciplinary event with 150+ participants sharing insights on #research, #precisionmedicine, and #pancreaticcancer care. Proud to see our PANCAIM team members attending and contributing! π
0
3
3
π Today is World Pancreatic Cancer Day 2024 π Every November, we come together to raise awareness and shine a light on one of the UKβs deadliest cancers. ποΈ Help us raise awareness, every conversation counts. Together, we can make a difference. π
1
14
13
At 4:30pm today the @QUBelfast historic Lanyon building will be lit up Purple for #WorldPancreaticCancer day All welcome to come along ππ https://t.co/rZ1Qmo5RCS
qub.ac.uk
1
10
38
Brilliant to see the impact of the EUROPAC study which we fund at @nhsUHLG. If you have pancreatitis, or more than one member of your family has been diagnosed with #PancreaticCancer, find out if regular monitoring could save your life:
pancreaticcancer.org.uk
Answer three quick questions to check your risk of pancreatic cancer and find out if you and your family may benefit from regular monitoring.
A fatherβs life has been saved thanks to a research trial to detect early #pancreaticcancer, a cancer with one of lowest survival rates ππ This #WorldPancreaticCancerDay Adam Eshborn, a research participant, has thanked the EUROPAC research team for spotting changes in his
0
7
23